发明名称 |
TUMOR VACCINATION INVOLVING A HUMORAL IMMUNE RESPONSE AGAINST SELF-PROTEINS |
摘要 |
The present invention relates to tumor immunotherapy, in particular to tumor vaccination, using chimeric proteins comprising all or a portion of a hepatitis B virus core antigen protein and an amino acid sequence comprising an epitope derived from the extracellular portion of a tumor-associated antigen. In particular, the present invention provides virus-like particles comprising said chimeric proteins, which are useful for eliciting a humoral immune response in a subject against the tumor-associated antigen, in particular against cells carrying said tumor-associated antigen on their surface, wherein the tumor-associated antigen is a self-protein in said subject. |
申请公布号 |
US2015152154(A1) |
申请公布日期 |
2015.06.04 |
申请号 |
US201414457897 |
申请日期 |
2014.08.12 |
申请人 |
BioNTech AG |
发明人 |
Klamp Thorsten;Sahin Ugur;Tureci Ozlem;Koslowski Michael;Hiller Thomas;Schumacher Jens |
分类号 |
C07K14/47;A61K39/00;C12N7/00;C07K14/005 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
1. A protein comprising all or a portion of the amino acid sequence of a hepatitis B virus core antigen protein and inserted therein or attached thereto an amino acid sequence comprising an epitope, wherein the epitope is derived from an extracellular portion of a tumor-associated antigen associated with the surface of a tumor cell. |
地址 |
Mainz DE |